[ad_1]
Morgan Stanley increased their target price on Pfizer from $32.00 to $33.00 and gave the company an “equal weight” rating in a research note on Wednesday.
[ad_2]
Source link
Pfizer (NYSE:PFE) Price Target Raised to $33.00 at Morgan Stanley